9-92332224-A-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001012267.3(CENPP):c.162A>T(p.Lys54Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000366 in 1,612,642 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001012267.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
CENPP | NM_001012267.3 | c.162A>T | p.Lys54Asn | missense_variant | 2/8 | ENST00000375587.8 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
CENPP | ENST00000375587.8 | c.162A>T | p.Lys54Asn | missense_variant | 2/8 | 1 | NM_001012267.3 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000250 AC: 38AN: 152218Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000441 AC: 11AN: 249716Hom.: 0 AF XY: 0.0000371 AC XY: 5AN XY: 134950
GnomAD4 exome AF: 0.0000144 AC: 21AN: 1460306Hom.: 0 Cov.: 30 AF XY: 0.00000964 AC XY: 7AN XY: 726404
GnomAD4 genome AF: 0.000249 AC: 38AN: 152336Hom.: 0 Cov.: 33 AF XY: 0.000295 AC XY: 22AN XY: 74484
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 03, 2022 | The c.162A>T (p.K54N) alteration is located in exon 2 (coding exon 2) of the CENPP gene. This alteration results from a A to T substitution at nucleotide position 162, causing the lysine (K) at amino acid position 54 to be replaced by an asparagine (N). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at